Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Salestools Logo

Salestools

Der #1 KI-Agent für Vertriebsteams und Go-to-Market-Teams. Verkaufen Sie mehr, schneller, mit weniger Aufwand.

Produkt

  • KI-Vertriebsagenten
  • Intent-Daten
  • Technologiedaten
  • Besucher-Tracking
  • Co-Pilot
  • Social Selling

Lösungen

  • Kundenservice
  • E-Commerce
  • SaaS
  • Enterprise
  • Kleinunternehmen

Ressourcen

  • Der Report
  • Dokumentation
  • API-Referenz
  • Hilfecenter
  • Blog
  • Fallstudien
  • Webinare

Unternehmen

  • Über uns
  • Karriere
  • Presse
  • Kontakt
  • Partner

Unsere Standorte

  • New York, HQ
  • Bukarest, KI-Forschungslabor
  • Zug, Schweiz

© 2025 Salestools. Alle Rechte vorbehalten.

Datenbedingungen & SicherheitDatenschutzerklärungNutzungsbedingungen
Alle Systeme betriebsbereit
Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Back to The Report
HealthTech

HorizonIntelligence

HorizonIntelligence Raises $40M Series B to Transform HealthTech

$40M Series B
Total Raised
Series
Latest Round
2024
Founded
100-250
Employees
Seattle, WA
Updated October 4, 2025
1 min read

Quick Facts

Valuation
$250M
Latest Round Size
$40M Series B
Latest Round Date
October 2025

HorizonIntelligence Raises $40M Series B in Latest Funding Round

HorizonIntelligence has successfully closed a $40M Series B funding round, marking a significant milestone in the company's growth trajectory. The round was led by Y Combinator, with participation from Sequoia Capital.

Company Overview

Founded in 2024 and headquartered in Seattle, WA, HorizonIntelligence has established itself in the HealthTech space. Leading telemedicine solution connecting patients with healthcare providers remotely

With a current valuation of $250M, the company has demonstrated strong market traction and investor confidence.

Investment Details

  • Amount Raised: $40M Series B
  • Valuation: $250M
  • Lead Investor: Y Combinator

Future Outlook

As HorizonIntelligence moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the healthtech space.

Key Investors

Y Combinator
Venture Capital
Leading venture capital firm investing in technology companies
Sequoia Capital
Venture Capital
Leading venture capital firm investing in technology companies

Topics

Venture Capital(911)Technology(815)Startup Funding(564)Series(545)HealthTech(503)

About the Author

Michael Torres
Michael Torres
Former startup founder turned investment analyst, focusing on early-stage technology and consumer companies.

Related Company Reports

HealthTech
Abridge

Abridge Raises $150M Series C to Transform HealthTech

Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...

Emma Rodriguez
Emma Rodriguez
Oct 22, 2025
0 min read•$150M Series C
HealthTech
Innovaccer

Innovaccer Raises $275M Series F to Transform HealthTech

Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...

Emma Rodriguez
Emma Rodriguez
Oct 22, 2025
0 min read•$275M Series F
HealthTech
Truveta

Truveta Raises $95M Series B to Transform HealthTech

Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...

Michael Torres
Michael Torres
Oct 22, 2025
0 min read•$95M Series B